Geneva Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	$527K	Buy	18,893 +891	+5%	+$24.9K	0.01%	503
2017 Q1	$619K	Buy	18,002 +1,396	+8%	+$48K	0.01%	450
2016 Q4	$479K	Buy	+16,606	New	+$479K	0.01%	489